Affera, Inc.

Affera, Inc. is a venture-backed medical device company founded in 2015 by a seasoned team of leaders in the industry. The company is focused on developing an innovative system to treat heart rhythm disorders, a prevalent condition affecting millions of patients worldwide. With its stronghold in the biotechnology and healthcare sectors, Affera operates from the United States. The company recently secured a $5.00M Venture Round investment on January 1, 2021, with Innogest Capital as the lead investor. Follow Affera as they continue to share updates about their progress in the field.